Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
22.00
+0.41 (1.90%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $48.31 million as of October 22, 2026. It is the 30,356th most valuable company in the world and the 4,640th biggest in the United States. Its market cap has decreased by 16.41% in one year.
Market Cap
48.31M
Enterprise Value
45.68M
1-Year Change
-16.41%
Global Rank
Country Rank
#4,640 United States
Category
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $48.31M, a decrease of -62.72%. That is a compound annual growth rate of -18.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 48.31M | 20.41% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 51.94M |
| Rein Therapeutics | 51.34M |
| Werewolf Therapeutics | 51.03M |
| MiNK Therapeutics | 50.32M |
| LeonaBio | 49.65M |
| Kalaris Therapeutics | 49.28M |
| Adicet Bio | 48.65M |
| Mereo BioPharma Group | 47.12M |